Mitochondrial creatine kinase in human health and disease

被引:475
作者
Schlattner, U [1 ]
Tokarska-Schlattner, M [1 ]
Wallimann, T [1 ]
机构
[1] Swiss Fed Inst Technol, ETH Zurich, Inst Cell Biol, CH-8093 Zurich, Switzerland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2006年 / 1762卷 / 02期
关键词
apoptosis; cardiomyopathy; crystalline intra-mitochondrial inclusion; energy metabolism; neurodegenerative disease; oxidative damage;
D O I
10.1016/j.bbadis.2005.09.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial creatine kinase (MtCK), together with cytosolic creatine kinase isoenzymes and the highly diffusible CK reaction product, phosphocreatine, provide a temporal and spatial energy buffer to maintain cellular energy homeostasis. Mitochondrial proteolipid complexes containing MtCK form microcompartments that are involved in channeling energy in form of phosphocreatine rather than ATP into the cytosol. Under situations of compromised cellular energy state, which are often linked to ischemia, oxidative stress and calcium overload, two characteristics of mitochondrial creatine kinase are particularly relevant: its exquisite susceptibility to oxidative modifications and the compensatory up-regulation of its gene expression, in some cases leading to accumulation of crystalline MtCK inclusion bodies in mitochondria that are the clinical hallmarks for mitochondrial cytopathies. Both of these events may either impair or reinforce, respectively, the functions of mitochondrial MtCK complexes in cellular energy supply and protection of mitochondria form the so-called permeability transition leading to apoptosis or necrosis. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 180
页数:17
相关论文
共 255 条
[1]   Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia [J].
Adcock, KH ;
Nedelcu, J ;
Loenneker, T ;
Martin, E ;
Wallimann, T ;
Wagner, BP .
DEVELOPMENTAL NEUROSCIENCE, 2002, 24 (05) :382-388
[2]   Oxidative modification of creatine kinase BB in Alzheimer's disease brain [J].
Aksenov, M ;
Aksenova, M ;
Butterfield, DA ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) :2520-2527
[3]   Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease [J].
Andreassen, OA ;
Dedeoglu, A ;
Ferrante, RJ ;
Jenkins, BG ;
Ferrante, KL ;
Thomas, M ;
Friedlich, A ;
Browne, SE ;
Schilling, G ;
Borchelt, DR ;
Hersch, SM ;
Ross, CA ;
Beal, MF .
NEUROBIOLOGY OF DISEASE, 2001, 8 (03) :479-491
[4]   Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation [J].
Andreassen, OA ;
Jenkins, BG ;
Dedeoglu, A ;
Ferrante, KL ;
Bogdanov, MB ;
Kaddurah-Daouk, R ;
Beal, MF .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (02) :383-390
[5]   Metabolic consequences of functional complexes of mitochondria, myofibrils and sarcoplasmic reticulum in muscle cells [J].
Andrienko, T ;
Kuznetsov, AV ;
Kaambre, T ;
Usson, Y ;
Orosco, A ;
Appaix, F ;
Tiivel, T ;
Sikk, P ;
Vendelin, M ;
Margreiter, R ;
Saks, VA .
JOURNAL OF EXPERIMENTAL BIOLOGY, 2003, 206 (12) :2059-2072
[6]  
APPLE FS, 1984, CLIN CHEM, V30, P413
[7]   In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death [J].
Azoulay-Zohar, H ;
Israelson, A ;
Abu-Hamad, S ;
Shoshan-Barmatz, V .
BIOCHEMICAL JOURNAL, 2004, 377 :347-355
[8]   Oxidatively modified proteins in aging and disease [J].
Beal, MF .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) :797-803
[9]   Energetics in the pathogenesis of neurodegenerative diseases [J].
Beal, MF .
TRENDS IN NEUROSCIENCES, 2000, 23 (07) :298-304
[10]  
Bergnes G, 1996, ONCOL RES, V8, P121